Skip to main content

Table 1 Comparison of demographic, atopic features and wheezing frequency according to asthma outcome

From: Utility of basophil activation test for predicting the outcome of wheezing in children: a pilot study

 

Non-asthma

(n = 17)

Asthma

(n = 26)

p value*

Sex, n(%)

 Male

7 (63.6)

21 (73.7)

> 0.05

 Female

4 (36.4)

6 (22.2)

Age, n(%)

 ≤ 3 years old

8 (72.7)

11 (40.7)

> 0.05

 3–5 years old

3 (27.3)

16 (59.3)

History of personal allergic diseases, n(%)

8 (72.7)

20 (74.7)

> 0.05

History of family allergic diseases, n(%)

4 (36.4)

16 (59.3)

> 0.05

sIgE, n(%)

5 (45.5)

21 (77.8)

> 0.05

Systemic glucocorticoid, n(%)

4 (36.4)

5 (18.5)

> 0.05

Wheezing frequency, n(%)

 <4

10 (90.9)

9 (33.3)

< 0.01

 ≥ 4

1 (9.1)

27 (66.7)

< 0.01

  1. Allergic disease: AR, AD and asthma; * Pearson Chi-Square test